A Chicago jury has decided that Johnson & Johnson’s DePuy Orthopaedics unit is not liable for the failure of a metal-on-metal hip implant that failed three years after an Illinois woman’s hip-replacement surgery.
A jury awarded $8.3 million in the first case to go to trial over metal-on-metal hip replacement implants, providing a sneak preview of what’s to come in mass tort litigation over Johnson & Johnson’s DePuy ASR XL product.
Published: March 7, 2013
Tags: American Medical Systems, Boston Scientific, C.R. Bard, Ethicon, Johnson & Johnson, medical device litigation, medical devices, multidistrict litigation, Prolift, vaginal mesh
In the first bellwether trial in the litigation over vaginal mesh products, a New Jersey jury awarded a 47-year-old woman $11 million in compensatory and punitive damages.
Published: March 1, 2013
Tags: Children’s Motrin, consumer protection, drug litigation, failure to warn, FDA, Food and Drug Administration, Johnson & Johnson, Motrin, preemption, Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis
A Massachusetts jury awarded $63 million to a teenaged girl and her parents after the girl suffered an adverse reaction to Children’s Motrin that left her scarred and blind, with permanent brain and lung damage.
And the award may increase.
A former dancer has withdrawn her claim against Johnson & Johnson over faulty hip replacements on the same day the trial was to start.
Drug maker Johnson & Johnson has settled approximately 845 product liability suits brought by individuals who claim they suffered tendon damage as a result of taking the antibiotic Levaquin.
Johnson & Johnson has agreed to pay a record $181 million to settle claims brought by New York and 36 other states that the company’s Janssen Pharmaceuticals unit improperly marketed Risperdal and other anti-psychotic drugs for “off-label” uses.
Published: June 7, 2012
Tags: Accutane, adverse events, Avandia, Bayer, Chantix, Coumadin, drug litigation, FDA, Food and Drug Administration, GlaxoSmithKline, Hoffman-LaRoche, Institute for Safe Medication Practices, Johnson & Johnson, Levaquin, Pfizer, Pradaxa, prescription drugs, Reglan, Wyeth, Yasmin, Yaz
The anti-nausea drug Reglan and its generic counterparts were the drugs most frequently cited in litigation in 2011, according to a consumer watchdog’s latest analysis of Food and Drug Administration statistics.
Women who use birth control patches like Ortho-Evra or contraceptive vaginal rings like NuvaRing have a heightened risk of blood clots, a new medical study has found.
A Texas jury awarded $482 million to a radiologist on his claim that a medical stent manufacturer willfully infringed his patent.